Stratos Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$225K Sell
1,616
-50
-3% -$7K 0.01% 557
2025
Q4
$204K Buy
+1,666
New +$202K 0.01% 625
2025
Q2
Sell
-1,924
Closed -$216K 690
2025
Q1
$216K Buy
+1,924
New +$199K 0.01% 614
2023
Q2
Sell
-3,328
Closed -$276K 634
2023
Q1
$276K Buy
3,328
+154
+5% +$12.8K 0.02% 507
2022
Q4
$273K Buy
+3,174
New +$251K 0.02% 489
2022
Q3
Sell
-3,647
Closed -$225K 506
2022
Q2
$225K Buy
+3,647
New +$226K 0.02% 471
2022
Q1
Sell
-4,656
Closed -$338K 541
2021
Q4
$338K Sell
4,656
-387
-8% -$26.7K 0.02% 444
2021
Q3
$352K Sell
5,043
-4,642
-48% -$326K 0.03% 408
2021
Q2
$667K Buy
9,685
+4,599
+90% +$307K 0.06% 308
2021
Q1
$329K Buy
5,086
+532
+12% +$34.3K 0.03% 379
2020
Q4
$265K Sell
4,554
-198
-4% -$11.9K 0.04% 335
2020
Q3
$300K Sell
4,752
-351
-7% -$24.3K 0.07% 254
2020
Q2
$393K Buy
5,103
+1,294
+34% +$99.2K 0.12% 169
2020
Q1
$285K Buy
3,809
+196
+5% +$13.5K 0.2% 112
2019
Q4
$235K Sell
3,613
-210
-5% -$13.7K 0.13% 146
2019
Q3
$242K Buy
3,823
+49
+1% +$3.2K 0.09% 218
2019
Q2
$255K Sell
3,774
-109
-3% -$7.17K 0.1% 197
2019
Q1
$252K Sell
3,883
-277
-7% -$18.4K 0.14% 177
2018
Q4
$260K Buy
+4,160
New +$291K 0.17% 154

Other funds holding GILD

Stratos Wealth Advisors's GILD Position: Q1 2026 in Review

Stratos Wealth Advisors reduced its Gilead Sciences (GILD) stake by 3% in Q1 2026, selling an estimated $7K and leaving 1,616 shares worth $225K. The position accounts for 0.01% of the portfolio, ranked #557.

Stratos Wealth Advisors first reported a position in GILD in Q4 2018 and has held it in 19 quarters since. The position peaked at $667K in Q2 2021. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Stratos Wealth Advisors held 1,616 shares of Gilead Sciences worth $225K as of Q1 2026.
  • Stratos Wealth Advisors sold 50 Gilead Sciences shares in Q1 2026, an estimated $7K.
  • Gilead Sciences made up 0.01% of Stratos Wealth Advisors's portfolio in Q1 2026, its #557 holding.
  • Stratos Wealth Advisors first reported a position in Gilead Sciences in Q4 2018 and has held it in 19 quarters since.
  • Stratos Wealth Advisors's Gilead Sciences position peaked at $667K in Q2 2021.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Stratos Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.